论文部分内容阅读
目的:分析联用奥扎格雷和舒血宁治疗急性脑梗死的效果。方法:选取该院收治的76例性脑梗死患者作为研究对象,采取等距随机抽样法分为观察组和对照组。对照组患者采用奥扎格雷进行临床治疗;观察组患者在对照组基础上联合使用舒血宁进行治疗。结果:两组患者治疗总有效率和不良反应情况比较,组间差异具有统计学意义(P<0.05)。结论:联用奥扎格雷和舒血宁治疗对急性脑梗死患者进行临床治疗,能够有效改善患者临床症状,疗效显著,具有临床应用及推广价值。
Objective: To analyze the effect of Ozagrel combined with Shuxuening in the treatment of acute cerebral infarction. Methods: Totally 76 patients with cerebral infarction admitted to our hospital were selected as the research object. The patients were randomly divided into observation group and control group. The patients in the control group were treated with ozagrel; the patients in the observation group were treated with Shuxuening on the basis of the control group. Results: The total effective rate and adverse reactions between the two groups were statistically significant (P <0.05). Conclusion: The combination of ozagrel and Shuxuening for clinical treatment of patients with acute cerebral infarction can effectively improve the clinical symptoms of patients with significant curative effect, which has clinical application and promotion value.